Dosimetric Effects of Bladder and Rectal Contrast Agents in Prostate Radiotherapy

Journal of Radiotherapy in Practice- United Kingdom

doi 10.1017/s1460396912000428

Full Text

Abstract

Available in

Date

Authors

Publisher

Cambridge University Press (CUP)

Related search

A Comparison of Dosimetric Parameters Between Tomotherapy and Three-Dimensional Conformal Radiotherapy in Rectal Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Dosimetric Impacts on Skin Toxicity for Patients Using Topical Agents and Dressings in Radiotherapy

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2016English

Variations in Dosimetric Distribution and Plan Complexity With Collimator Angles in Hypofractionated Volumetric Arc Radiotherapy for Treating Prostate Cancer

Journal of Applied Clinical Medical Physics
InstrumentationNuclear MedicineRadiologyRadiationImagingMedicine
2018English

Dosimetric Evaluation of the Skin-Sparing Effects of 3-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Left Breast Cancer

Oncotarget
Oncology
2016English

Radiotherapy for Urinary Bladder Pheochromocytoma With Invasion of the Prostate: A Case Report and Literature Review

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Developments in Neoadjuvant Chemotherapy and Radiotherapy in Rectal Cancer

2012English

Dosimetric Evaluation of the Radiation Exposure on Radiotherapy Workers

Journal of Health Sciences and Medicine
2020English

Sexual Quality of Life Following Prostate Intensity Modulated Radiotherapy (IMRT) With a Rectal/Prostate Spacer: Secondary Analysis of a Phase III Trial

Practical Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2018English

Chemoprevention of Bladder and Prostate Carcinoma

Cancer Control
MedicineOncologyHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy